Lixte Biotechnology Holdings, Inc.
LIXTLixte Biotechnology Holdings, Inc.
NASDAQ
Healthcare
Biotechnology
$3.14
+0.07(2.4%)
52W $0.71 – $6.01
Quick:
10-K
Mar 31, 2026 (6 days ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 10, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 18, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 31, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 23, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 22, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 11, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 25, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Sep 11, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Sep 4, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 19, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 14, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 7, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Jul 21, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jul 16, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jul 11, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
S-1/A
Jul 10, 2025 (9 months ago)Registration Statement (Amendment)
IPO or secondary offering
Pricing, dilution, use of proceeds
8-K
Jul 8, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jul 3, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction